ClinCraft

ClinCraft is an AI-powered platform that helps biotech, pharma, and clinical research organizations design better trials, faster. Rather than building protocols manually through slow, iterative, expensive cycles, users input their trial specifications — conditions, clinical phase, study model, endpoints, eligibility criteria, patient information, biomarkers, regulatory requirements, allocation, and target country — and ClinCraft's AI-driven simulations return an optimized, submission-ready protocol.

Built on original algorithmic generation models and complete industry data coverage, and developed in partnership with AWS and NVIDIA, ClinCraft delivers across four core service areas:

• Trial design optimization — original AI models streamline protocol design, saving significant time and cost from the earliest stage of study planning.

• Regulatory assistance — the platform helps automate the regulatory submission process and predicts likely obstacles across regions before they cause delays.

• Predictive modeling — ClinCraft forecasts trial outcomes, reduces costly amendments, optimizes dosing, and shortens overall timelines.

• Targeted recruitment — it identifies diverse and underrepresented patient populations, improving both representation and enrollment speed.

Beyond trial execution, ClinCraft supports the wider drug development pathway — from target and compound identification, SAR studies, and sequence-based drug design through to formulation optimization and global regulatory compliance for drugs and biologics. By connecting clinical, disease, and molecular data in one AI-driven environment, ClinCraft improves the quality of clinical data, strengthens collaboration between investigators and sponsors, and advances fairer access to treatments — saving developers up to nine months per trial, in a field where delays can cost as much as £500k per day.